The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta-analysis.

In patients with intermediate risk PE, the risk of bleeding is higher when thrombolysis is used. There was no significant difference between thrombolysis and anticoagulation in recurrence of PE, stroke, and all-cause mortality.